Indian Journal of Pharmacy Practice logo
Submit
Indian Journal of Pharmacy PracticeACADEMIC PUBLISHING
Review

Adverse Drug Reaction Tools Used in Causality Assessment

1, 1, 1, 1

  1. 1Department of Pharmacy Practice, Adichunchanagiri University, B.G Nagara, Karnataka, INDIA..

CORRESPONDENCE

Akshay Mohan

Department of Pharmacy Practice, Adichunchanagiri University, B.G Nagara, Karnataka, INDIA..

akshaymohan4499@gmail.com

Received: 17-07-2023; Accepted: 14-09-2023.

Volume 16, Issue 4 · pp. 281-2588 · 2023 · DOI: 10.5530/ijopp.16.4.50

ABSTRACT

Adverse Drug Reactions (ADRs) tools are very significant in the detection, assessment, and severity of ADRs. This review emphasizes the most frequently utilized causality assessment scales, for example, the WHO-Uppsala Monitoring Centre Causality Assessment System, the Naranjo algorithm for the ADR assessment, the Liverpool Causality Assessment Tool (LCAT), and the Roussel Uclaf Causality Assessment Method (RUCAM). Bayesian Adverse Reactions Diagnostic Instrument (BARDI). In this review we found that the most commonly preferred tool is Naranjo Algorithm and the most commonly used combination is the WHO-Uppsala Monitoring Centre causality assessment system and the Naranjo algorithm. Large numbers of causality appraisal strategies have their benefits and burdens. In any case, Due to variation and inconsistency, no single causality assessment measure has been accepted and utilised globally. No single scale, however, has been accepted as standardised and taken into consideration for widespread acceptability.

KEYWORDS

Open in new tab

REFERENCES

As published

Showing references and in-text citations exactly as published.

    Cite this article

    SELECT FORMAT

    Kumaraswamy, M., Mohan, A., Chonari, T. A., & Dahim, M. (2023). Adverse Drug Reaction Tools Used in Causality Assessment. Indian Journal of Pharmacy Practice, 16(4), 281-2588. https://doi.org/10.5530/ijopp.16.4.50

    Copyright and licence

    © 2023 Author(s)

    This is an open access article distributed under the terms of the Creative Commons Attribution 4.0 License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. CC BY 4.0